# Advantis Medical Imaging

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/advantis-medical-imaging

- Industry: Internet
- Headquarters: Eindhoven, Netherlands
- Website: www.advantis.io
- Total disclosed funding: $0.8M
- Latest round: Seed (Mar 12, 2019)
- Investors on record: 2

## About

Advantis Medical Imaging develops advanced imaging software, focusing on automated MRI analysis for brain and prostate examinations, aimed at enhancing diagnostic efficiency.Founded in 2016, Advantis Medical Imaging is based in Eindhoven, Netherlands, where it specializes in imaging software solutions. The company was co-founded by Dimitris Rozakis, Paris Ziogkas, and Zoi Giavri. Advantis has engaged in 2 notable deals, with the most recent being a Seed funding round of EUR 0.7 million led by Metavallon VC on March 12, 2019. The total amount raised by the company is EUR 0.7 million.Advantis Medical Imaging specializes in advanced imaging software, primarily focusing on MRI analysis for brain and prostate examinations. Their core offering, Advantis Brain (Brainance MD), is a web-based platform that utilizes sophisticated algorithms for the automated analysis of MRI brain scans, including Diffusion Tensor Imaging (DTI) and functional MRI (fMRI). This platform is designed to streamline workflow for healthcare professionals, allowing for anonymized data uploading and one-click preprocessing, which enhances efficiency and accuracy in diagnosing various brain pathologies. The software supports clinical applications in neurosurgery, neuroradiology, and neuropsychology, enabling professionals to engage in detailed analysis without being constrained by hardware specifications. Advantis serves a diverse clientele that includes hospitals and research institutions across Europe, North America, and Australia, focusing on multidisciplinary healthcare teams requiring high-quality imaging solutions.Advantis Medical Imaging operates primarily on a subscription-based revenue model, providing access to its software solutions through various pricing plans tailored to institutional needs. Clients, which include healthcare facilities and research organizations, typically engage in agreements that allow for the use of the Advantis Brain platform, facilitating advanced imaging analyses and automated reporting. Revenue is generated through direct sales of software subscriptions as well as potential partnerships with healthcare providers that enhance their imaging capabilities. The company’s flagship product, Advantis Brain (Brainance MD), is central to its financial structure, as it not only drives user engagement but also underscores the company’s commitment to improving workflow efficiency in radiological practices. Specific transaction structures reflect a B2B focus, allowing institutions to integrate the software into their existing systems seamlessly.Advantis Medical Imaging plans to utilize the EUR 0.7 million raised in Seed funding in March 2019 to enhance its product offerings and expand its market reach. The company is focusing on developing new features for Advantis Brain, aiming for a release by the end of 2024. Furthermore, Advantis is targeting expansion into North American and Asian markets, aiming to establish a presence in these regions by 2025.

## Funding rounds

- Seed, Mar 12, 2019, $0.8M — Metavallon VC
- Seed, Jun 1, 2017 — VentureFriends

## Investors

- VentureFriends (https://capitalatlas.ai/funds/venturefriends) — Seed
- Metavallon VC (https://capitalatlas.ai/funds/metavallon-vc) — Seed